Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03880825 · ClinicalTrials.gov registry record · Phase 1
Drug Interaction Study of Levoketoconazole and Metformin
A Phase 1 study, sponsored by Cortendo AB.
- Completed
- Registry status
- Phase 1
- Development phase
- 32
- Enrollment target
NCT03880825 is a Phase 1 study that has completed, run by Cortendo AB. The registered enrollment target is 32 participants.
The verdict
NCT03880825, a Phase 1 study, has completed, sponsored by Cortendo AB.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 32 participants
- Enrollment target
Study Summary
This is a phase I, open-label, fixed-sequence drug-drug interaction study to evaluate the effect of levoketoconazole on the single-dose PK of metformin in health subjects.
Interventions
- DRUG Metformin 500 mg Oral Tablet
- DRUG Levoketoconazole 150 - 600 mg (BID)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 32 participants |
| Start Date | 2019-03-28 |
| Est. Completion | 2019-05-03 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03880825
The ClinicalTrials.gov registry entry for NCT03880825 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 32 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Cortendo AB, which has 6 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Metformin 500 mg Oral Tablet is the first listed.
NCT03880825 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03880825 about?
NCT03880825 is a clinical study titled "Drug Interaction Study of Levoketoconazole and Metformin". This is a phase I, open-label, fixed-sequence drug-drug interaction study to evaluate the effect of levoketoconazole on the single-dose PK of metformin in health subjects.
What is the current status of trial NCT03880825?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 32 participants. The study started on 2019-03-28. Estimated completion is 2019-05-03.
What interventions are being tested in trial NCT03880825?
The interventions under investigation include: Metformin 500 mg Oral Tablet (DRUG), Levoketoconazole 150 - 600 mg (BID) (DRUG).
Who is sponsoring clinical trial NCT03880825?
This trial is sponsored by Cortendo AB, which has 6 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.